Prazma, Charlene M.
Bel, Elisabeth H.
Price, Robert G.
Bradford, Eric S.
Albers, Frank C.
Yancey, Steven W.
Funding for this research was provided by:
GSK (NA)
Article History
Received: 19 December 2018
Accepted: 24 April 2019
First Online: 3 May 2019
Ethics approval and consent to participate
: This was a post hoc analysis of the SIRIUS study; the original study protocol was approved by the appropriate investigational center ethics committee or institutional review board in accordance with the International Conference on harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Good Publication Practice (GPP). All patients provided their consent.
: Not applicable.
: CMP, RGP, ESB, FCA and SWY are all employees of GSK and hold shares in GSK. EHB reports grants and personal fees from GSK.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.